Dr. Eric Berg DC · 2026-07-17 · Eric Berg (host), Steve, Tahira, Manuel, Piba, Canal

The Dr. Berg Show LIVE - July 17, 2026

38 research-tied claims examined: 3 contradicted 1 contradicted online 4 overstated 7 context 19 supported 4 unverified

Overstated

Vitamin D, vitamin K2, and magnesium help alleviate vertigo by managing calcium crystal accumulation in the inner ear.

"vitamin D and vitamin K2 and magnesium do help with that because of the calcium crystals that build up." (said at 0:28:47)

Benign paroxysmal positional vertigo (BPPV) is caused by dislodged calcium carbonate crystals (otoconia) entering the semicircular canals of the inner ear. There is evidence that vitamin D deficiency is associated with BPPV and that vitamin D supplementation may reduce BPPV recurrence in patients with deficiency. However, there is no clinical trial evidence demonstrating that vitamin K2 or magnesium supplementation prevents, treats, or alleviates vertigo or clears calcium crystal accumulation in the inner ear. While magnesium is a trace structural component of human otoconia crystals, claims that supplementing vitamin K2 and magnesium manages otoconial vertigo represent an extrapolation beyond clinical evidence.

context: Magnesium as an intrinsic component of human otoconia. (Acta oto-laryngologica 2018) · cited 1x in the literature
"Magnesium is an intrinsic component of human otoconia by partial substitution of calcium in the calcite crystal structure (Ca 1-x Mg x ) and affects the development of the shape of artificial otoconia (calcite gelatin composites, CGC)." (abstract, conclusions, passage verified)
pubmed full study (doi)
partial: Association between vitamin D, vitamin D supplementation and benign paroxysmal positional … (Frontiers in neurology 2025) · cited 9x in the literature
"The serum level of vitamin D is lower in patients with BPPV, especially recurrent BPPV, than in controls. There was a negative correlation between occurrence rate of BPPV episodes and vitamin D deficiency, which means that vitamin D deficiency may have a role in occurrence of BPPV. The present study indicates that vitamin D supplementation can significantly lower recurrence in benign paroxysmal positional vertigo." (abstract, conclusions, passage verified)
pubmed full study (doi)

0:31:38 Eric Berg (host)overstatedlow

Hepatic hemangiomas are estrogen-sensitive benign vascular clusters that shrink in postmenopausal women.

"That's a cluster of blood vessels in the liver. It's benign; it won't turn into a tumor. Sometimes it's related to estrogen, and so this is why in postmenopausal females it shrinks with age." (said at 0:31:38)

Hepatic hemangiomas are benign vascular lesions of the liver whose growth is influenced by female sex hormones, and exogenous estrogen therapy can stimulate their enlargement. However, claiming that hemangiomas routinely shrink with age in postmenopausal women overstates the evidence. Prospective natural history studies show that most hepatic hemangiomas remain stable in size over long-term follow-up, and while spontaneous regression following menopause or cessation of hormone therapy can occur, it is documented in published literature as a rare phenomenon rather than a predictable or typical outcome.

context: Hepatic haemangiomas: possible association with female sex hormones. (Gut 2004) · cited 170x in the literature
"Hepatic haemangiomas seem to be influenced by both endogenous and exogenous female sex hormones although significant enlargement occurs only in a minority of patients." (abstract, conclusions, passage verified)
pubmed full study (doi)
partial: Gradual spontaneous regression of hepatic hemangioma in a woman with surgical menopause: A… (Radiology case reports 2026) · cited 1x in the literature
"Hepatic hemangiomas (HHs), the most common benign liver tumors, may grow, remain stable, or rarely regress spontaneously, with regression potentially associated with reduced estrogen levels." (abstract, background, passage verified)
pubmed full study (doi)

0:52:30 Eric Berg (host)overstatedhigh

A clinical study showed that heavy resistance weight training reversed osteopenia and osteoporosis in women and salvaged muscle.

"Now you might you might think that there was an interesting study related to women that were they had osteopenia and osteoporosis and you would think that you would have to be very very fragile and careful and everything and and you have to do this safely, but they put these women on um heavier weights and and had done it on a gradient correctly and not only did they get rid of their osteopenia and osteoporosis, but they salvaged their muscles." (said at 0:52:30)

The speaker appears to be referring to the LIFTMOR trial (and related work), a randomized controlled trial investigating supervised high-intensity resistance and impact training (HiRIT; >85% 1-repetition maximum) in postmenopausal women with low to very low bone mass (osteopenia and osteoporosis). The trial demonstrated that progressive heavy resistance training is safe and significantly improves lumbar spine bone mineral density (+2.9%), femoral neck bone mineral density (+0.3%), cortical thickness, and muscle strength/functional performance compared to low-intensity controls who lost bone density. However, claiming that the intervention 'got rid of' or completely reversed osteopenia and osteoporosis overstates the magnitude of the effect, as a modest percentage increase in bone mineral density improves bone strength and mitigates age-related bone loss but does not eliminate or fully cure established osteopenia or osteoporosis.

partial: Heavy resistance training is safe and improves bone, function, and stature in postmenopaus… (Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2015) · cited 112x in the literature
"HiPRT and impact loading (n = 12) improved height (0.4 ± 0.2 cm vs -0.3 ± 0.1 cm, p = 0.003), femoral neck bone mineral density (0.3 ± 0.5 % vs -2.5 ± 0.8 %, p = 0.016), lumbar spine bone mineral density (1.6 ± 0.9 % vs -1.7 ± 0.6 %, p = 0.005), and functional performance (p < 0.05), compared to controls (n = 16)." (abstract, results, passage verified)
pubmed full study (doi)
partial: High-Intensity Resistance and Impact Training Improves Bone Mineral Density and Physical F… (Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2018) · cited 445x in the literature
"HiRIT (n = 49) effects were superior to CON (n = 52) for lumbar spine (LS) BMD (2.9 ± 2.8% versus -1.2 ± 2.8%, p < 0.001), femoral neck (FN) BMD (0.3 ± 2.6% versus -1.9 ± 2.6%, p = 0.004), FN cortical thickness (13.6 ± 16.6% versus 6.3 ± 16.6%, p = 0.014), height (0.2 ± 0.5 cm versus -0.2 ± 0.5 cm, p = 0.004), and all functional performance measures (p < 0.001)." (abstract, results, passage verified)
pubmed full study (doi)

0:43:43 Eric Berg (host)overstatedlow

Magnesium enhances sleep quality by supporting GABA neurotransmission in the brain.

"Well, magnesium will help not just sleep, but it will help with the quality of sleep, GABA in your brain. I think it can greatly assist in all aspects of sleep problems." (said at 0:43:43)

Preclinical and mechanistic literature indicates that magnesium acts as an NMDA receptor antagonist and positive modulator of GABAergic neurotransmission, which plays an important role in central nervous system inhibition and sleep architecture. However, clinical evidence demonstrating that magnesium supplementation reliably improves sleep quality or resolves overall sleep problems remains limited and inconsistent. Systematic reviews and meta-analyses of randomized controlled trials (such as those by Mah & Pitre, 2021, and Arab et al., 2023) note modest improvements in subjective measures such as sleep onset latency in specific populations (primarily older adults with insomnia), but report that available trials are small, have moderate-to-high risk of bias, and provide low to very low certainty of overall clinical benefit.

context: The effect of magnesium supplementation on primary insomnia in elderly: A double-blind pla… (Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences 2012) · cited 114x in the literature
"The natural N-methyl-D-aspartic acid (NMDA) antagonist and GABA agonist, Mg(2+), seems to play a key role in the regulation of sleep." (abstract, introduction, passage verified)
pubmed
partial: Oral magnesium supplementation for insomnia in older adults: a Systematic Review & Meta-An… (BMC complementary medicine and therapies 2021) · cited 52x in the literature
"Three randomized control trials (RCT) were identified comparing oral magnesium to placebo in 151 older adults in three countries. Pooled analysis showed that post-intervention sleep onset latency time was 17.36 min less after magnesium supplementation compared to placebo (95% CI - 27.27 to - 7.44, p = 0.0006)... All trials were at moderate-to-high risk of bias and outcomes were supported by low to very low quality of evidence." (abstract, results, passage verified)
pubmed full study (doi)
partial: The Role of Magnesium in Sleep Health: a Systematic Review of Available Literature. (Biological trace element research 2023) · cited 74x in the literature
"This systematic review revealed an association between magnesium status and sleep quality (daytime falling asleep, sleepiness, snoring, and sleep duration) according to the observational studies, while the randomized clinical trials showed an uncertain association between magnesium supplementation and sleep disorders." (abstract, results, passage verified)
pubmed full study (doi)

Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.